Monday, May 23, 2022
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Bharat Biotech Asked To Provide More Data On Covid 19 Vaccine Covaxin For Below 12 Year Olds

Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

By ANI
Published: Published Date - 01:00 PM, Fri - 22 April 22

New Delhi: The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.

This development comes after the Subject Expert Committee discussed recommendations for the restricted emergency of Covaxin in children aged between 2-12 years.

No recommendations have been made as of now, sources told ANI.

However, the SEC, after a meeting on Thursday, has recommended restricted emergency use of Biological E’s COVID-19 vaccine, Corbevax, in children aged 5-12 years, said sources. Now DCGI will be giving approval for its emergency use authorisation.

The Corbevax vaccine is currently being administered to children in the age group of 12-14 years.

The vaccination drive for children in the age group of 15-18 years commenced on January 3 this year.They are being administered Covaxin.

The drive later expanded on March 16 to include children aged between 12-14 years. They are being administered Corbevax.

Overall, India is currently administering two COVID-19 vaccines to children above 12 years.

  • Follow Us :
  • Tags
  • Bharat Biotech
  • Covaxin
  • COVID-19 vaccine

Related News

  • India’s cumulative COVID-19 vaccine coverage exceeds 188.89 Cr

  • Covaxin receives emergency use approval in children aged between 6 and 12

  • Ocugen to commercialise Covaxin in Mexico

  • Covaxin, Covishield to cost Rs 225 per dose

  • Bharat Biotech announces slowing down of Covaxin production

  • Bharat Biotech: A journey of 2 suitcases and 40 feet container

Latest News

  • Hyderabad NRI dies after falling from building in Makkah

    6 mins ago
  • Sarat Pattanayak appointed Congress’ new Odisha chief

    4 mins ago
  • Chhattisgarh moves SC against bail to senior IPS officer in graft case

    16 mins ago
  • No more drunk driving: Hyderabad Traffic Police resumes late night checking

    18 mins ago
  • Woman killed, 44 injured as tractor trolley overturns in Kothagudem

    22 mins ago
  • Kothagudem: Man beats wife to death in Paloncha

    22 mins ago
  • NT, TT to conduct free awareness programme on preparation for recruitment tests on May 24

    28 mins ago
  • Four State Awards for City College in Jignasa competitions

    4 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam